New research points to a possible link between GLP-1 drugs and slower biological aging, as covered by the Texas station.
Recap by typeshit. Full story at cbs19.tv.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The Kashvi Hospital managing director, a metabolic specialist, weighs weight loss injections against surgery as a treatment option.
McIntyre says he gets asked about this worldwide and shares a summary of the mechanistic data on GLP-1 drugs and loss of pleasure.
Loading…